CME Group Inc (CME) Shares Sold by Nomura Holdings Inc.

Nomura Holdings Inc. lessened its holdings in shares of CME Group Inc (NASDAQ:CME) by 91.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 2,964 shares of the financial services provider’s stock after selling 31,587 shares during the period. Nomura Holdings Inc.’s holdings in CME Group were worth $485,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CME. Janus Henderson Group PLC raised its position in shares of CME Group by 13.2% during the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after acquiring an additional 716,655 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in shares of CME Group during the 2nd quarter worth about $96,350,000. Unigestion Holding SA acquired a new stake in shares of CME Group during the 2nd quarter worth about $96,251,000. Westfield Capital Management Co. LP raised its position in shares of CME Group by 777.5% during the 1st quarter. Westfield Capital Management Co. LP now owns 610,726 shares of the financial services provider’s stock worth $98,779,000 after acquiring an additional 541,126 shares in the last quarter. Finally, Epoch Investment Partners Inc. raised its position in shares of CME Group by 51.9% during the 1st quarter. Epoch Investment Partners Inc. now owns 1,545,562 shares of the financial services provider’s stock worth $249,980,000 after acquiring an additional 528,198 shares in the last quarter. 83.98% of the stock is currently owned by institutional investors and hedge funds.

In other CME Group news, Director Ronald A. Pankau sold 260 shares of CME Group stock in a transaction that occurred on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the transaction, the director now directly owns 3,900 shares in the company, valued at approximately $636,363. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Bryan T. Durkin sold 11,509 shares of CME Group stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $162.01, for a total value of $1,864,573.09. Following the completion of the transaction, the president now owns 64,862 shares in the company, valued at $10,508,292.62. The disclosure for this sale can be found here. Insiders sold a total of 29,188 shares of company stock worth $4,934,232 over the last quarter. Company insiders own 0.43% of the company’s stock.

Several equities research analysts have recently weighed in on the company. Berenberg Bank set a $184.00 target price on CME Group and gave the stock a “hold” rating in a research report on Thursday, September 20th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Rosenblatt Securities assumed coverage on CME Group in a research report on Wednesday, September 5th. They set a “neutral” rating and a $177.00 target price on the stock. Jefferies Financial Group reissued a “buy” rating and set a $190.00 target price on shares of CME Group in a research report on Wednesday, September 5th. Finally, BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 18th. Five research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $178.36.

NASDAQ:CME opened at $173.60 on Wednesday. The company has a market cap of $59.33 billion, a P/E ratio of 29.57, a PEG ratio of 3.28 and a beta of 0.64. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a 52-week low of $132.33 and a 52-week high of $177.35.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.02. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.22 EPS. research analysts expect that CME Group Inc will post 6.65 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 25th. Shareholders of record on Monday, September 10th were paid a $0.70 dividend. The ex-dividend date of this dividend was Friday, September 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.61%. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: Average Daily Trade Volume – What You Need to Know

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply